MILWAUKEE (WISN) — Epilepsy is the most common chronic brain disease, with nearly 3 million adults in the U.S. diagnosed. Epilepsy can be disruptive, dangerous and terrifying. But, there is a way for ...

Epilepsy remains one of the most misunderstood neurological disorders, affecting nearly 12 million Indians. While anti-seizure medications are the first line of treatment, about 30% of patients ...

Miles Lewis had his first seizure at 4 years old. He was diagnosed with epilepsy after those seizures kept happening He was put on medication, but eventually a team of doctors at Johns Hopkins All ...

Jennifer Alvis was diagnosed with epilepsy when she was four years old. Now 40 years old and seizure-free, Alvis jokes that it took 36 years for technology to catch up so she could receive the care ...

Please provide your email address to receive an email when new articles are posted on . Diagnosis delays are the main challenge in addressing pediatric epilepsy. Neuromodulation techniques for ...

– New patient implants assigned to New Technology Ambulatory Payment Classification 1580 – End-of-service procedures elevated to Level 5 APC – Effective Jan. 1, 2026, will improve economics for ...

A new technique has enabled ultra-powerful magnetic resonance imaging (MRI) scanners to identify tiny differences in patients' brains that cause treatment-resistant epilepsy. In the first study to use ...

LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced that the U.S. Centers for Medicare & Medicaid Services (CMS) assigned VNS Therapy™, a LivaNova neuromodulation ...